IPO

IPO Snapshot

Asston Pharmaceuticals Ltd.

Issue Open Date	09-Jul-25
Issue Closing Date	11-Jul-25
Application Money	100
Allotment Money

Price Band ()	115 - 123
Minimum Bid Quantity.	2000
Issue Size (Shares)	1606000
Market Lot	1

Objective

1. Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit 2. Funding the incremental working capital requirements of our Company 3. Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by ourCompany and4. General Corporate Purposes

Business Description

Our Company is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products indomestic and various African markets. Our Company operates under brand “Asston”. Presently, our Company is involved in thebusiness of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel andLotion) and Oral Powder (Sachet,...

Promoter's Holding

Total Share Capital	4331680
Offered to Public	1606000
Promoter's Holding (Pre-Issue)	69.07
Promoter's Holding (Post-Issue)	50.66

Address

Address :4th Floor
Office No A-431
Balaji Bhavan
Plot No 42 A
Sector-11 Cbd Belapur
Navi Mumbai City :Thane, State :Maharashtra Pincode :400614 Phone :022 49731419 / 49731411 Email : aston.tech14@gmail.com Website : www.asstonpharmaceuticals.com

Registrar

Maashitla Securities Pvt Ltd.
451
Krishna Apra Business
Square
Netaji Subhash Place

Pitampura
New Delhi

Listed at

BSE

Lead Manager

Sobhagya Capital Options Ltd

Promoters

Ashish Narayan Sakalkar
Sachin Chandrakant Badakh
Saili Jayaram More

ATTENTION INVESTORS
KYC
CDSL

Prevent Unauthorized Transactions in your demat and trading account --> Update your Mobile Number/Email id with your Depository Participant and Stock Broker. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat/trading account directly from CDSL and Stock Exchanges on the same day.........issued in the interest of investors...

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

2. Update your Mobile Number & Email Id with your Stock Broker/ Depository Participant and receive OTP directly from Depository on your Email Id and/ or Mobile Number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued by NSE vide. Circular No. NSE/INSP/45191 dated: July 31, 2020 and NSE/INSP/45534 and BSE vide Notice No. 20200731-7, dated: July 31, 2020 and 20200831- 45 dated: August 31, 2020 and dated: August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities/ MF/ Bonds in the Consolidated Account Statement issued by NSDL/ CDSL every month.

6. Risk disclosures RISK DISCLOSURES ON DERIVATIVES:

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html
We believe that an educated investor is a protected investor !!!

"As per the directives of CDSL and esteemed Exchanges, it has been made mandatory for every client to furnish their latest KYC details viz. Valid Mobile No., Email- Id & Income range on or before 31.05.2021 else your Account will be marked as Non Compliant and will be Freezed till the compliance of such requirement."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

Dear Investor if you wish to revoke your un-executed eDis mandate, please mail us with ISIN and quantity on dp@indiratrade.com by today EOD."

REGISTRATION NOS:

INDIRA SECURITIES PRIVATE LIMITED (SEBI REG.NO.):NSE TMID: 12866, BSE TMID: 663, CDSL DPID: 17000 SEBI REG. NO.: INZ000188930, MCX TM ID: 56470, NCDEX TM ID: 01277, CDSL REG. NO.: IN-DP-90-2015, CIN: U67120MH1996PTC160201, RA SEBI REG. No.: INH000023269

DISCLAIMER:

"INVESTMENT IN SECURITIES MARKET ARE SUBJECT TO MARKET RISKS, READ ALL THE RELATED DOCUMENTS CAREFULLY BEFORE INVESTING."

INVESTORS GRIEVANCE

Vimalesh Ajmera. Email: compliance@indiratrade.com. Call : 0731-4797275

Investor grievance complaint : complaint@indiratrade.com

INVESTOR CHARTER

For Voluntary Freezing/Blocking of Trading Account you can mail us at stoptrade@indiratrade.com or call us at 9109937435.